MetaCap

Who Owns Cullinan Therapeutics Stock?

NASDAQ: CGEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.89-0.18 (-1.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
110.53%
Institutional holders
261
  • Institutions 99.4%
  • Insiders 0.6%
  • Public and other 0.0%

Who owns Cullinan Therapeutics stock?

Institutional investors own about 110.5% of Cullinan Therapeutics's shares, spread across 261 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.58% of CGEM.

The largest institutional holders are MPM Bioimpact LLC (14.99%), Lynx1 Capital Management Lp (13.81%) and BVF Inc. (8.86%). Together, the top 10 institutions control 70.9% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CGEM positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CGEM

Cullinan Therapeutics top institutional holders
InstitutionShares% HeldChange
MPM Bioimpact LLC9.73M14.99%+27.2%
Lynx1 Capital Management Lp8.96M13.81%0.0%
BVF Inc.5.75M8.86%0.0%
Blackrock Inc.5.23M8.06%+17.6%
Price (T.Rowe) Associates Inc3.83M5.89%+88.5%
Kynam Capital Management, LP3.11M4.80%0.0%
Vanguard Capital Management LLC2.61M4.03%+5.3%
State Street Corporation2.60M4.01%-29.0%
RTW Investments LP2.36M3.64%+38.6%
Siren, L.L.C.1.79M2.76%-5.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CGEM

Cullinan Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.93M2.97%
iShares Trust-iShares Russell 2000 ETF1.57M2.42%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.23M1.89%
T. Rowe Price New Horizons Fund, Inc.1.02M1.57%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund662.88K1.02%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund621.22K0.96%
T. Rowe Price Health Sciences Fund, Inc.583.80K0.90%
iShares Trust-iShares Russell 2000 Value ETF573.55K0.88%
T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U.559.80K0.86%
TR PRICE-Price (T.Rowe) New Horizons Trust452.66K0.70%

Frequently asked questions

Who is the largest shareholder of Cullinan Therapeutics?

MPM Bioimpact LLC is the largest institutional shareholder of CGEM, owning 14.99% of shares outstanding (9.73M shares) as of its latest 13F filing.

What percentage of Cullinan Therapeutics is owned by institutions?

Institutions own about 110.5% of CGEM shares and 111.2% of the public float.

How much of Cullinan Therapeutics do insiders own?

Insiders, such as officers and directors, own about 0.58% of CGEM shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related